{
    "sec_cik": "0000064803",
    "sec_company_name": "CVS HEALTH Corp (Filer)",
    "document_type": "EX991",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20180104",
    "sec_filing_date": "20180104",
    "sec_changed_date": "20180104",
    "sec_accepted_date": "20180104071432",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/64803/000119312518002185/0001193125-18-002185-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/64803/000119312518002185/0001193125-18-002185.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0007\004\CVS_0000064803_EX991_20180104_EX-99_metadata.json",
    "original_file_name": "",
    "original_file_size": "26027 chars",
    "document_group": "EX-99",
    "section_name": "EX-99",
    "section_n_characters": 19957,
    "endpoints": [
        "EX-99.1   ",
        "CVS Health, Aetna, their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of CVS Health is set forth in its Annual Report on Form 10-K for the year ended December 31, 2016 (“CVS Health’s Annual Report”), which was filed with the SEC on February 9, 2017, its proxy statement for its 2017 annual meeting of stockholders, which was filed with the SEC on March 31, 2017, and its Current Report on Form 8-K, which was filed with the SEC on May 12, 2017. Information about the directors and executive officers of Aetna is set forth in its Annual Report on Form 10-K for the year ended December 31, 2016 (“Aetna’s Annual Report”), which was filed with the SEC on February 17, 2017, its proxy statement for its 2017 annual meeting of shareholders, which was filed with the SEC on April 7, 2017 and its Current Reports on Form 8-K, which were filed with the SEC on May 24, 2017 and October 2, 2017. Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available."
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "CVS",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0007\004\CVS_0000064803_EX991_20180104_EX-99_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 7,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 22:17:42.947739",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 22:30:27.239282"
}